KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Equity Income: 2019-2023

Historic Equity Income for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Dec 2023 value amounting to -$2.6 million.

  • Ginkgo Bioworks Holdings' Equity Income fell 111.19% to -$1.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was $7.4 million, marking a year-over-year increase of 116.84%. This contributed to the annual value of -$2.6 million for FY2023, which is 93.98% up from last year.
  • Ginkgo Bioworks Holdings' Equity Income amounted to -$2.6 million in FY2023, which was up 93.98% from -$43.8 million recorded in FY2022.
  • In the past 5 years, Ginkgo Bioworks Holdings' Equity Income ranged from a high of -$396,000 in FY2020 and a low of -$77.3 million during FY2021.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median Equity Income value was -$43.8 million (recorded in 2022), while the average stood at -$41.2 million.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Equity Income spiked by 98.56% in 2020 and then plummeted by 19,416.16% in 2021.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' Equity Income stood at -$27.5 million in 2019, then soared by 98.56% to -$396,000 in 2020, then plummeted by 19,416.16% to -$77.3 million in 2021, then soared by 43.38% to -$43.8 million in 2022, then spiked by 93.98% to -$2.6 million in 2023.